EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study

Ru Liu, Haibo Liu, Deshan Yuan, Yan Chen, Xiaofang Tang, Ce Zhang, Pei Zhu, Tao Yang, Yongbao Zhang, Han Li, Ou Xu, Runlin Gao und 2 weitere

Clinical Cardiology · 2023-06 · 46 (6) · 680-688

DOI: 10.1002/clc.24021 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Cardiology, online erschienen am 28.04.2023. Verfasst von Ru Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Real‐world data on target vessel of percutaneous coronary intervention (PCI) for patients with prior coronary artery bypass grafting (CABG) was still limited. Hypothesis A prospective cohort was examined to determine the frequency and outcomes of native coronary artery PCI versus bypass graft PCI in patients with prior CABG.

Methods

A large‐sample observational study enrolled a total of 10 724 patients with coronary artery disease (CAD) underwent PCI in 2013. Two‐ and five‐year clinical outcomes were compared between graft PCI group and native artery PCI group in patients with prior CABG.

Results

A total of 438 cases had CABG history in the total cohort. Graft PCI group and native artery PCI group accounted for 13.7% and 86.3%, respectively. The rates of 2‐ and 5‐year all‐cause death and major adverse cardiovascular and cerebral events (MACCE) showed no significant difference between the two groups ( p > .05). Two‐year revascularization risk was lower in graft PCI group than native artery PCI group (3.3% and 12.4%, p < .05), but 5‐year myocardial infarction (MI) risk was higher (13.3% and 5.0%, p < .05). In multivariate COX regression models, graft PCI group was independently associated with lower 2‐year revascularization risk (hazard ratio [HR]: 0.21; 95% confidence interval [CI]: 0.05–0.88; p = .033), but higher 5‐year MI risk than native artery PCI group (HR: 2.61; 95% CI: 1.03–6.57; p = .042). Five‐year all‐cause death and MACCE risk showed no difference between the two groups in model.

Conclusions

In patients with prior CABG underwent PCI, patients in graft PCI group had higher 5‐year MI risk than patients received native artery PCI. But, 5‐year mortality and MACCE was not significantly different between graft PCI group and native artery PCI group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePercutaneous Coronary InterventionMyocardial InfarctionHumansFollow-Up StudiesProspective StudiesTreatment OutcomeCoronary Artery Bypass

Stichwörter der Autor:innen

coronary artery bypass graftingcoronary artery diseasepercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Respiratory and Pulmonary Vascular Disease, Fuwai Yunnan Cardiovascular Hospital, Kunming, China.
  • Department of Adult Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Vascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Förderung

  • National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center Project
  • Beijing United Heart Foundation

Zitieren

APA

Liu, R., Liu, H., Yuan, D., Chen, Y., Tang, X., Zhang, C., Zhu, P., Yang, T., Zhang, Y., Li, H., Xu, O., Gao, R., Xu, B., & Yuan, J. (2023). For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study. Clinical Cardiology, 46(6), 680-688. https://doi.org/10.1002/clc.24021

Vancouver

Liu R, Liu H, Yuan D, Chen Y, Tang X, Zhang C, et al. For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study. Clinical Cardiology. 2023;46(6):680-688. doi:10.1002/clc.24021

BibTeX
@article{Liu2023,
  author = {Liu, Ru and Liu, Haibo and Yuan, Deshan and Chen, Yan and Tang, Xiaofang and Zhang, Ce and Zhu, Pei and Yang, Tao and Zhang, Yongbao and Li, Han and Xu, Ou and Gao, Runlin and Xu, Bo and Yuan, Jinqing},
  title = {For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study},
  journal = {Clinical Cardiology},
  year = {2023},
  volume = {46},
  number = {6},
  pages = {680--688},
  doi = {10.1002/clc.24021}
}
Kostenlos starten →